Corrigendum: Effective management of atherosclerosis progress and hyperlipidemia with nattokinase: A clinical study with 1,062 participants.
Frontiers in cardiovascular medicine（2022）
Key words
Nattokinase (NK),anti-atherogenic drug,atherosclerosis,hyperlipidaemia,lipid lowering agent,lipid lowering effect,nattokinase,retrospective study
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined